Much has been said about the Brazilian market and the significant conquests its health sector has recently made compared with past decades. In order to be successful, it is imperative to know the singularities of the market
This document discusses trends in emerging pharmaceutical markets, focusing on Brazil, Russia, India, and China. It provides an overview of the current healthcare systems and pharmaceutical markets in each country. Some key points discussed include growth patterns in developed markets flattening while emerging markets see significant growth potential. The document also outlines future trends in each country such as increasing regulation, emphasis on generics, and strategies pharmaceutical companies can employ to succeed in these emerging markets.
This presentation is intended to educate anyone wishing to distribute a product in Latin America. Although it is healthcare specific, it may be used as a guide for any other products.
The hospital segment in India is becoming increasingly attractive for pharmaceutical companies due to its large size, fast growth rate, and investment opportunities. However, pharmaceutical companies will need to rethink their business strategies to succeed in this evolving market. Hospitals are exerting more control over physician prescriptions and purchasing decisions. Additionally, the relationship between physicians and hospitals is shifting, with hospitals gaining more influence. To effectively engage with the hospital segment, pharmaceutical companies will need to tailor their strategies, products, targeting, and metrics to the unique dynamics of each hospital type.
The global pharmaceutical drugs market was valued around $935 billion in 2017. North America was the largest region in the pharmaceutical drugs market in 2017, accounting for around 37% of the total market.
Read Report
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report-2018
The pharmacy channel in Malaysia has been growing faster than other healthcare channels since 2007, with a compound annual growth rate of 12.25% according to IMS Health data. The growth of pharmacies is due to an increasing number of retail outlets, more trained pharmacists, and patients becoming more comfortable obtaining medications directly from pharmacists. However, multinational pharmaceutical companies will need to adapt to Malaysia's changing healthcare landscape which includes a push to separate medication dispensing from physician offices to retail pharmacies. This will increase pressure on brand name drugs that traditionally relied on doctor prescriptions.
Global pharmaceutical companies are modeled with a supply chain, which ensures that the right drug reaches the right people at the right time and in the right condition. The supply chain also ensures 100% product availability at optimum cost by carrying huge inventory, which maintains 100% fill rate. Manufacturers are trying to cut down development time to save costs. For example, a drug manufacturer who can trim development time by 19% can save up to USD 100 million. But if a drug is getting delayed to reach the market, the time delay costs the company around USD 1 million a day. So, pharmaceutical companies today are designing the supply chain to be as responsive as possible to reduce entry time to the market thereby increasing profit margins.
Momenta Pharmaceuticals is a biotechnology company focused on developing generic versions of complex drugs and biosimilars. It has one approved product, a generic version of Lovenox, and received approval for a generic version of Copaxone in 2015. The company partners with larger drug manufacturers for commercialization who obtain marketing approval. Momenta earns revenue through profit sharing, royalties, licensing fees, and research services. It has a pipeline of 10 drug candidates and sees its partnership with MIT and proprietary sequencing technology as competitive advantages. Historically the company has experienced fluctuating revenues and losses as it funds research and development but maintains liquidity through investments in market securities.
This document discusses trends in emerging pharmaceutical markets, focusing on Brazil, Russia, India, and China. It provides an overview of the current healthcare systems and pharmaceutical markets in each country. Some key points discussed include growth patterns in developed markets flattening while emerging markets see significant growth potential. The document also outlines future trends in each country such as increasing regulation, emphasis on generics, and strategies pharmaceutical companies can employ to succeed in these emerging markets.
This presentation is intended to educate anyone wishing to distribute a product in Latin America. Although it is healthcare specific, it may be used as a guide for any other products.
The hospital segment in India is becoming increasingly attractive for pharmaceutical companies due to its large size, fast growth rate, and investment opportunities. However, pharmaceutical companies will need to rethink their business strategies to succeed in this evolving market. Hospitals are exerting more control over physician prescriptions and purchasing decisions. Additionally, the relationship between physicians and hospitals is shifting, with hospitals gaining more influence. To effectively engage with the hospital segment, pharmaceutical companies will need to tailor their strategies, products, targeting, and metrics to the unique dynamics of each hospital type.
The global pharmaceutical drugs market was valued around $935 billion in 2017. North America was the largest region in the pharmaceutical drugs market in 2017, accounting for around 37% of the total market.
Read Report
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report-2018
The pharmacy channel in Malaysia has been growing faster than other healthcare channels since 2007, with a compound annual growth rate of 12.25% according to IMS Health data. The growth of pharmacies is due to an increasing number of retail outlets, more trained pharmacists, and patients becoming more comfortable obtaining medications directly from pharmacists. However, multinational pharmaceutical companies will need to adapt to Malaysia's changing healthcare landscape which includes a push to separate medication dispensing from physician offices to retail pharmacies. This will increase pressure on brand name drugs that traditionally relied on doctor prescriptions.
Global pharmaceutical companies are modeled with a supply chain, which ensures that the right drug reaches the right people at the right time and in the right condition. The supply chain also ensures 100% product availability at optimum cost by carrying huge inventory, which maintains 100% fill rate. Manufacturers are trying to cut down development time to save costs. For example, a drug manufacturer who can trim development time by 19% can save up to USD 100 million. But if a drug is getting delayed to reach the market, the time delay costs the company around USD 1 million a day. So, pharmaceutical companies today are designing the supply chain to be as responsive as possible to reduce entry time to the market thereby increasing profit margins.
Momenta Pharmaceuticals is a biotechnology company focused on developing generic versions of complex drugs and biosimilars. It has one approved product, a generic version of Lovenox, and received approval for a generic version of Copaxone in 2015. The company partners with larger drug manufacturers for commercialization who obtain marketing approval. Momenta earns revenue through profit sharing, royalties, licensing fees, and research services. It has a pipeline of 10 drug candidates and sees its partnership with MIT and proprietary sequencing technology as competitive advantages. Historically the company has experienced fluctuating revenues and losses as it funds research and development but maintains liquidity through investments in market securities.
The document discusses the Archer Class submarines in service with the Republic of Singapore Navy (RSN). The submarines were originally Swedish Västergötland Class diesel-electric submarines that underwent an upgrade program, which included the addition of an air independent propulsion system to increase underwater endurance and stealth capabilities. The first submarine, RSS Archer, was launched in 2009 and commissioned in 2011, while the second, RSS Swordsman, was launched in 2010 and entered service in 2013.
Brazil's healthcare market is poised for significant growth driven by multiple factors. The expansion of the middle class will increase the number of insured people in Brazil. Increased availability of generic drugs and biosimilars will make medications more accessible. Government investments and initiatives like SUS aim to improve and expand healthcare access. Rapid disease burden growth areas include obesity, diabetes, cancer and hypertension. Overall, Brazil's complex but evolving healthcare system and market represent a major opportunity for both existing players and new entrants.
This document provides an agenda for the 10th Latin America Treasury & Finance Conference in 2013. The conference will take place from May 6-8, 2013 in Miami, Florida and feature five tracks on the economy, doing business, best practices, connectivity, and trends in Latin America. Some of the topics to be discussed include the economic outlook and opportunities in Latin America, strategies for multilatinas expanding globally, urbanization and infrastructure development, supply chain finance, priorities for treasury professionals, and building regional treasury models. The agenda outlines presentations and panel discussions across the three day event focused on providing insights and practical strategies for treasury and finance professionals operating in Latin America.
I am pleased to present here my reseach-based book, entitled ‘Great Minds on INDIA’, containing the quotes of the world-renowned intellectual giants on ancient Indian literature. This fervent appreciation of classical knowledge and wisdom by the wisest of the wise rational scholars from the West must be a matter nation’s pride and a subject to be made aware to all and one. Yes indeed, it is quite astonishing that all these truths about richness of Indian system of knowledge have been less discussed or brought to light in INDIA. So far our students have not been encouraged to learn in schools or colleges about the timeless philosophies as the Vedanta, Yoga literature, and the likes in any manner which in fact have become a core source of inspiration for many of the secular and rational Western poets, philosophers, scientists et al.
One wonders in amazement why we are not being taught in the schools the fact that Pythagoras came to India to learn Geometry and Spiritualism all the way from Greece who was quite senior to Socrates and Plato.
The publication of this book is intended exclusively for the dissemination of the time immemorial secular and value-based wisdom of this ancient land.
- Brazil has a population of over 205 million people and is urbanizing rapidly
- Life expectancy has been increasing and is now over 74 years
- The fertility rate and birth rate have been declining steadily over time
- Non-communicable diseases like heart disease and cancer are leading causes of mortality
- Mortality rates for children and communicable diseases have decreased significantly in recent decades
The SMX-Océan is a conventionally powered attack submarine design concept unveiled by DCNS Group in 2014. It is based on the nuclear-powered Barracuda-class submarine, retaining its basic layout, weapons, masts, and combat system. The SMX-Océan submarine will have a diesel-electric propulsion system and air independent propulsion for underwater endurance of up to 21 days. It is designed to carry out escort and patrol missions while equipped with 34 weapons systems, including torpedoes, mines, missiles, and vertical launchers.
Submarine earthquakes occur underwater at the bottom of bodies of water and are caused by the movement of tectonic plates under the sea floor. When pressure builds up at plate boundaries due to friction, it is suddenly released, causing the earthquake. This can generate destructive tsunamis that travel across the ocean and heavily damage coastal areas. Understanding plate tectonics helps explain why different types of plate boundaries like convergent or transform faults result in submarine quakes. Historic examples include the 1960 Chile earthquake, the largest ever at magnitude 9.5.
The document summarizes pharmaceutical market indicators in Brazil from 2003-2013 based on data from IMS Health. It shows that the total Brazilian pharmaceutical market grew from $2.2 billion in January-June 2003 to $13.4 billion in the same period in 2013. Generics sales increased from $130 million to $3.1 billion over the same time frame. Exports of pharmaceutical products increased from $1 billion to $3.1 billion from 2003-2013 while imports rose from $2.8 billion to $7 billion. The consumer price index for pharmaceuticals saw accumulated inflation rates between 3.5-5.6% annually from 2011-2013. Unit sales of pharmaceutical products and generics also increased substantially from 2003
This document provides a comprehensive list of all classes of submarines in the United States Navy, from the earliest experimental models in the 1860s to classes developed through World War I. It describes 18 different classes ranging from small, hand-powered prototypes to larger ocean-going submarines with diesel engines. Each class entry includes details on number of boats, specifications, propulsion systems, and armaments.
This document discusses US Navy submarine classes, including their missions and deployment cycles. It describes the key characteristics and capabilities of the Los Angeles, Seawolf, Virginia, and Ohio classes of fast attack submarines (SSN), ballistic missile submarines (SSBN), and guided missile submarines (SSGN). Submarine missions covered include intelligence gathering, mine warfare, anti-submarine warfare, anti-surface ship warfare, strike warfare, and strategic deterrence.
This document provides an overview of submarine (or U-boat) geography during World War II. It discusses key aspects such as:
- U.S. and German submarine designs from WWII
- The readiness of the U.S. submarine fleet at the start of the war
- Problems with early U.S. torpedo technology
- Offensive submarine tactics developed by German commander Donitz, including close-range attacks and wolfpack formations
- Defensive measures taken by Allied forces like convoy routes and anti-submarine warfare
- Locations of major German U-boat bunkers constructed during the war
In 3 sentences or less, it summarizes key information about submarine warfare during WWII.
I am pleased to present here my reseach-based book, entitled ‘Great Minds on INDIA’, containing the quotes of the world renowned intellectual giants on ancient Indian literature. This fervent appreciation of classical knowledge and wisdom by the wisest of the wise rational scholars from the West must be a matter nation’s pride and a subject to be made aware to all and one. Yes indeed, it is quite astonishing that all these truths about richness of Indian system of knowledge have been less discussed or brought to light in INDIA. So far our students have not been encouraged to learn in schools or colleges about the timeless philosophies as the Vedanta, Yoga literature, and the likes in any manner which in fact have become a core source of inspiration for many of the secular and rational Western poets, philosophers, scientists et al.
One wonders in amazement why we are not being taught in the schools the fact that Pythagoras came to India to learn Geometry and Spiritualism all the way from Greece who was quite senior to Socrates and Plato.
The publication of this book is intended exclusively for the dissemination of the time immemorial secular and value-based wisdom of this ancient land.
The USS Nautilus was the first nuclear-powered submarine, launched in 1955. In response, the Soviet Union began developing nuclear submarines in the 1950s under Anatoliy Alexandrov, with their first nuclear submarine entering service in 1958. By eliminating the need for oxygen, nuclear submarines can remain submerged indefinitely limited only by food and water supplies. Today, the United States, Russia, France, United Kingdom, and China operate nuclear submarine fleets, with the US and UK relying solely on nuclear submarines. Nuclear submarines are expected to continue playing an important role in naval defense for many years.
Submarines have existed since the late 16th century but became increasingly important weapons in World War I and II when German U-boats wreaked havoc on Allied ships. During this time, submarines evolved from hand-powered vessels to diesel-electric and eventually nuclear-powered ships. The first nuclear submarine, USS Nautilus, launched in 1954 and could stay submerged for long periods without needing to surface. Modern submarines use sonar and periscopes for navigation and targeting systems to fire torpedoes or missiles at enemy vessels from long distances. Life onboard is difficult, with cramped conditions and no sunlight for months during long deployments.
Forbidden Photos of North Korea by Photographer Eric Lafforguemaditabalnco
Eric, a photographer who visited North Korea, was banned from the country after publishing photos online that the North Korean government deemed too offensive. The photos aimed to show the reality and hardship of life in North Korea, rather than portraying the country and its people as propaganda does. However, many scenes the government wants to keep hidden from the outside world, such as poverty, malnutrition, and signs of labor, are common in Eric's photos from his trips to North Korea. Officials closely monitor photographers and often request that photos depicting anything contrary to the regime's message be deleted.
This document discusses many magazine covers that caused controversy due to their provocative or politically charged nature. Some of the covers mentioned include Janet Jackson on Rolling Stone, Dzhokhar Tsarnaev on Rolling Stone after the Boston bombings, Demi Moore posing nude and pregnant on Vanity Fair, and Time magazine asking "Is God Dead?" on their cover in 1966 which received significant backlash. The document also notes controversial covers featuring celebrities like Britney Spears, Kanye West, and Miley Cyrus among others.
Market Access for Specialty Products in Latin Americaexecutiveinsight
Executive Insight examines the market access challenges and opportunities specifically for premium, specialty inpatient products in the Latin American (LatAm) region
The document summarizes key information about Brazil's consumer healthcare market from 2014 to 2021:
- Brazil has the second largest consumer healthcare market in the Americas behind the US, with sales topping $6 billion in 2015.
- While economic downturns slowed growth in 2015-2016, the market continues to outperform other retail sectors as employment and incomes rise.
- The market remains highly complex with both private and public healthcare systems. Majority of consumer products can only be sold in pharmacies, which are dominated by three large chains.
- Regulatory approval can take 1.5 to 4 years and advertising must follow strict ANVISA guidelines, though recent changes may increase competition and shift to consumer marketing.
-
Brazil An Emerging Partner In Drug R&Dnielsleidecker
1) Brazil has improved its infrastructure, scientific capabilities, and strategic initiatives to promote drug discovery research. Positive economic growth, political stability, expanding patient populations, and increasing governmental and private investments are creating new opportunities for drug R&D in Brazil.
2) The Brazilian pharmaceutical market is the largest in Latin America, with increasing investments from both domestic and multinational companies. The government has also established laboratories and initiatives to promote local innovation and reduce reliance on imports.
3) Brazil possesses natural resources and biodiversity that could provide opportunities for new drug discoveries, especially through partnerships between domestic and international researchers utilizing Brazilian expertise and technologies.
The growing 50+ market, driven by the demand and spending power of the baby boomer generations, is changing the global economy and also offers big opportunities for Finnish companies.
The document discusses the Archer Class submarines in service with the Republic of Singapore Navy (RSN). The submarines were originally Swedish Västergötland Class diesel-electric submarines that underwent an upgrade program, which included the addition of an air independent propulsion system to increase underwater endurance and stealth capabilities. The first submarine, RSS Archer, was launched in 2009 and commissioned in 2011, while the second, RSS Swordsman, was launched in 2010 and entered service in 2013.
Brazil's healthcare market is poised for significant growth driven by multiple factors. The expansion of the middle class will increase the number of insured people in Brazil. Increased availability of generic drugs and biosimilars will make medications more accessible. Government investments and initiatives like SUS aim to improve and expand healthcare access. Rapid disease burden growth areas include obesity, diabetes, cancer and hypertension. Overall, Brazil's complex but evolving healthcare system and market represent a major opportunity for both existing players and new entrants.
This document provides an agenda for the 10th Latin America Treasury & Finance Conference in 2013. The conference will take place from May 6-8, 2013 in Miami, Florida and feature five tracks on the economy, doing business, best practices, connectivity, and trends in Latin America. Some of the topics to be discussed include the economic outlook and opportunities in Latin America, strategies for multilatinas expanding globally, urbanization and infrastructure development, supply chain finance, priorities for treasury professionals, and building regional treasury models. The agenda outlines presentations and panel discussions across the three day event focused on providing insights and practical strategies for treasury and finance professionals operating in Latin America.
I am pleased to present here my reseach-based book, entitled ‘Great Minds on INDIA’, containing the quotes of the world-renowned intellectual giants on ancient Indian literature. This fervent appreciation of classical knowledge and wisdom by the wisest of the wise rational scholars from the West must be a matter nation’s pride and a subject to be made aware to all and one. Yes indeed, it is quite astonishing that all these truths about richness of Indian system of knowledge have been less discussed or brought to light in INDIA. So far our students have not been encouraged to learn in schools or colleges about the timeless philosophies as the Vedanta, Yoga literature, and the likes in any manner which in fact have become a core source of inspiration for many of the secular and rational Western poets, philosophers, scientists et al.
One wonders in amazement why we are not being taught in the schools the fact that Pythagoras came to India to learn Geometry and Spiritualism all the way from Greece who was quite senior to Socrates and Plato.
The publication of this book is intended exclusively for the dissemination of the time immemorial secular and value-based wisdom of this ancient land.
- Brazil has a population of over 205 million people and is urbanizing rapidly
- Life expectancy has been increasing and is now over 74 years
- The fertility rate and birth rate have been declining steadily over time
- Non-communicable diseases like heart disease and cancer are leading causes of mortality
- Mortality rates for children and communicable diseases have decreased significantly in recent decades
The SMX-Océan is a conventionally powered attack submarine design concept unveiled by DCNS Group in 2014. It is based on the nuclear-powered Barracuda-class submarine, retaining its basic layout, weapons, masts, and combat system. The SMX-Océan submarine will have a diesel-electric propulsion system and air independent propulsion for underwater endurance of up to 21 days. It is designed to carry out escort and patrol missions while equipped with 34 weapons systems, including torpedoes, mines, missiles, and vertical launchers.
Submarine earthquakes occur underwater at the bottom of bodies of water and are caused by the movement of tectonic plates under the sea floor. When pressure builds up at plate boundaries due to friction, it is suddenly released, causing the earthquake. This can generate destructive tsunamis that travel across the ocean and heavily damage coastal areas. Understanding plate tectonics helps explain why different types of plate boundaries like convergent or transform faults result in submarine quakes. Historic examples include the 1960 Chile earthquake, the largest ever at magnitude 9.5.
The document summarizes pharmaceutical market indicators in Brazil from 2003-2013 based on data from IMS Health. It shows that the total Brazilian pharmaceutical market grew from $2.2 billion in January-June 2003 to $13.4 billion in the same period in 2013. Generics sales increased from $130 million to $3.1 billion over the same time frame. Exports of pharmaceutical products increased from $1 billion to $3.1 billion from 2003-2013 while imports rose from $2.8 billion to $7 billion. The consumer price index for pharmaceuticals saw accumulated inflation rates between 3.5-5.6% annually from 2011-2013. Unit sales of pharmaceutical products and generics also increased substantially from 2003
This document provides a comprehensive list of all classes of submarines in the United States Navy, from the earliest experimental models in the 1860s to classes developed through World War I. It describes 18 different classes ranging from small, hand-powered prototypes to larger ocean-going submarines with diesel engines. Each class entry includes details on number of boats, specifications, propulsion systems, and armaments.
This document discusses US Navy submarine classes, including their missions and deployment cycles. It describes the key characteristics and capabilities of the Los Angeles, Seawolf, Virginia, and Ohio classes of fast attack submarines (SSN), ballistic missile submarines (SSBN), and guided missile submarines (SSGN). Submarine missions covered include intelligence gathering, mine warfare, anti-submarine warfare, anti-surface ship warfare, strike warfare, and strategic deterrence.
This document provides an overview of submarine (or U-boat) geography during World War II. It discusses key aspects such as:
- U.S. and German submarine designs from WWII
- The readiness of the U.S. submarine fleet at the start of the war
- Problems with early U.S. torpedo technology
- Offensive submarine tactics developed by German commander Donitz, including close-range attacks and wolfpack formations
- Defensive measures taken by Allied forces like convoy routes and anti-submarine warfare
- Locations of major German U-boat bunkers constructed during the war
In 3 sentences or less, it summarizes key information about submarine warfare during WWII.
I am pleased to present here my reseach-based book, entitled ‘Great Minds on INDIA’, containing the quotes of the world renowned intellectual giants on ancient Indian literature. This fervent appreciation of classical knowledge and wisdom by the wisest of the wise rational scholars from the West must be a matter nation’s pride and a subject to be made aware to all and one. Yes indeed, it is quite astonishing that all these truths about richness of Indian system of knowledge have been less discussed or brought to light in INDIA. So far our students have not been encouraged to learn in schools or colleges about the timeless philosophies as the Vedanta, Yoga literature, and the likes in any manner which in fact have become a core source of inspiration for many of the secular and rational Western poets, philosophers, scientists et al.
One wonders in amazement why we are not being taught in the schools the fact that Pythagoras came to India to learn Geometry and Spiritualism all the way from Greece who was quite senior to Socrates and Plato.
The publication of this book is intended exclusively for the dissemination of the time immemorial secular and value-based wisdom of this ancient land.
The USS Nautilus was the first nuclear-powered submarine, launched in 1955. In response, the Soviet Union began developing nuclear submarines in the 1950s under Anatoliy Alexandrov, with their first nuclear submarine entering service in 1958. By eliminating the need for oxygen, nuclear submarines can remain submerged indefinitely limited only by food and water supplies. Today, the United States, Russia, France, United Kingdom, and China operate nuclear submarine fleets, with the US and UK relying solely on nuclear submarines. Nuclear submarines are expected to continue playing an important role in naval defense for many years.
Submarines have existed since the late 16th century but became increasingly important weapons in World War I and II when German U-boats wreaked havoc on Allied ships. During this time, submarines evolved from hand-powered vessels to diesel-electric and eventually nuclear-powered ships. The first nuclear submarine, USS Nautilus, launched in 1954 and could stay submerged for long periods without needing to surface. Modern submarines use sonar and periscopes for navigation and targeting systems to fire torpedoes or missiles at enemy vessels from long distances. Life onboard is difficult, with cramped conditions and no sunlight for months during long deployments.
Forbidden Photos of North Korea by Photographer Eric Lafforguemaditabalnco
Eric, a photographer who visited North Korea, was banned from the country after publishing photos online that the North Korean government deemed too offensive. The photos aimed to show the reality and hardship of life in North Korea, rather than portraying the country and its people as propaganda does. However, many scenes the government wants to keep hidden from the outside world, such as poverty, malnutrition, and signs of labor, are common in Eric's photos from his trips to North Korea. Officials closely monitor photographers and often request that photos depicting anything contrary to the regime's message be deleted.
This document discusses many magazine covers that caused controversy due to their provocative or politically charged nature. Some of the covers mentioned include Janet Jackson on Rolling Stone, Dzhokhar Tsarnaev on Rolling Stone after the Boston bombings, Demi Moore posing nude and pregnant on Vanity Fair, and Time magazine asking "Is God Dead?" on their cover in 1966 which received significant backlash. The document also notes controversial covers featuring celebrities like Britney Spears, Kanye West, and Miley Cyrus among others.
Market Access for Specialty Products in Latin Americaexecutiveinsight
Executive Insight examines the market access challenges and opportunities specifically for premium, specialty inpatient products in the Latin American (LatAm) region
The document summarizes key information about Brazil's consumer healthcare market from 2014 to 2021:
- Brazil has the second largest consumer healthcare market in the Americas behind the US, with sales topping $6 billion in 2015.
- While economic downturns slowed growth in 2015-2016, the market continues to outperform other retail sectors as employment and incomes rise.
- The market remains highly complex with both private and public healthcare systems. Majority of consumer products can only be sold in pharmacies, which are dominated by three large chains.
- Regulatory approval can take 1.5 to 4 years and advertising must follow strict ANVISA guidelines, though recent changes may increase competition and shift to consumer marketing.
-
Brazil An Emerging Partner In Drug R&Dnielsleidecker
1) Brazil has improved its infrastructure, scientific capabilities, and strategic initiatives to promote drug discovery research. Positive economic growth, political stability, expanding patient populations, and increasing governmental and private investments are creating new opportunities for drug R&D in Brazil.
2) The Brazilian pharmaceutical market is the largest in Latin America, with increasing investments from both domestic and multinational companies. The government has also established laboratories and initiatives to promote local innovation and reduce reliance on imports.
3) Brazil possesses natural resources and biodiversity that could provide opportunities for new drug discoveries, especially through partnerships between domestic and international researchers utilizing Brazilian expertise and technologies.
The growing 50+ market, driven by the demand and spending power of the baby boomer generations, is changing the global economy and also offers big opportunities for Finnish companies.
Pharmaceutical industry pestel analysisRahul Pagaria
The pharmaceutical industry in India is a rapidly growing sector that produces low-cost, high-quality drugs. It has a total market size of over $20 billion and has grown at around 12.5% annually over the past five years. Key players in the industry include Ranbaxy, Dr. Reddy's, Cipla, and Lupin. A PESTEL analysis identified political issues like price controls, social factors like an aging population and increased patient expectations, economic challenges from the global crisis, opportunities from new technologies, and an increasing focus on the environmental impact of the industry.
Growing Pains. China new's realities and the necessity of an informed strateg...QuintilesIMS Asia Pacific
China is a rapidly evolving healthcare market. However companies that take too macroscopic approach to projecting growth, disregarding the more granular trends across drug categories, risk facing a gap between assumed and actual portfolio growth. To address this gap, companies have a variety of options, ranging across levels of difficulty and the degree of transformation necessary.
Download the paper to learn more.
MANA Healthcare Marketing Report 2015_FINALMANA LLC
The document discusses trends in healthcare marketing in 2015, including:
1) The Affordable Care Act taking full effect, making Americans more cost-conscious healthcare consumers.
2) Pharmaceutical companies adapting to value-based pricing models that link drug costs to health outcomes rather than volume.
3) Growth of personalized medicine and diagnostics that improve care while reducing costs, though companies face challenges demonstrating value.
4) Rapid growth of telemedicine and remote health monitoring technologies that improve access and efficiency in healthcare.
Brazil had a healthcare expenditure of $222.71 billion in 2011 and was the largest pharmaceutical market and third largest medical devices market in Latin America. The government is increasing funding for healthcare and providing free or low-cost medicines for conditions like hypertension and diabetes. Brazil also aims to boost its pharmaceutical industry and reduce reliance on imports by investing in research and developing domestic generic and biosimilar drug markets. However, corruption and intellectual property issues remain challenges.
This document outlines a public relations campaign plan for Abbvie Inc. It provides background on the pharmaceutical industry, Abbvie's history and strengths/weaknesses. Key publics are identified that the campaign will target to increase support for Abbvie's mission. Strategies and tactics are defined to convey the messaging accurately with high recall potential. An evaluation plan is included to determine how well the message is being communicated and resonating with key publics. The document then outlines the budget, calendar and references to support a successful PR campaign for Abbvie.
New Global Healthcare Another Chapter In Healthcare Marketing Brand ManagementJGB1
Emerging healthcare markets are moving into new phases as access to care increases and clinical / payer administration becomes more established. Successful healthcare marketing ventures require a balanced clinical / cost value proposition based on each nation\'s specific healthcare delivery, government and payer model.
Pharmaceutical industry in bangladesh(assigment)...n iloyNiloy Saha
The document discusses the pharmaceutical sector in Bangladesh. It provides background on the history and growth of the pharmaceutical industry in Bangladesh. Key points include:
- The pharmaceutical sector has grown significantly since the 1980s and is now a major contributor to Bangladesh's economy. It supplies 97% of domestic medicine needs.
- The industry is highly regulated by bodies like the Directorate General of Drug Administration. The National Drug Policy of 1982 helped foster growth by promoting local production and restricting imports.
- Major local companies include Square Pharmaceuticals, Incepta Pharma, Beximco Pharma, and ACME Laboratories. The industry also includes some multinational companies.
- In 2012, Square Pharma
Global Healthcare Marketing is evolving as emerging markets quickly mature. Clinical standards, payer structures and marketing messages are a combination of variables to be accounted for in unlocking market access challenges.
www.healthcaremedicalpharmaceuticaldirectory.com - a healthcare industry resource
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
Global healthcare marketing strategies and tactics are being re-positioned as emerging markets mature, access to care increases and clinical / payer administration becomes more established.
China, Brazil, India, Saudi Arabia
www.healthcaremedicalpharmaceuticaldirectory.com
John G. Baresky
https://www.linkedin.com/in/johngbaresky
#baresky
The document discusses the changing landscape for pharmaceutical marketing in China, noting that compliance concerns, restrictions on promotional activities, and drug approval lags are forcing companies to transition from sales-driven to more strategic, marketing-focused models. Interviews with industry executives found that while China remains important, challenges around market access, disconnects between policy and implementation, and macroeconomic factors are affecting business. The paper aims to explore the context of changes in China's healthcare system and offer recommendations for how companies can adapt their marketing approaches.
Successfully Accessing Medical Equipment Markets in CIVETS Available on Rese...QYResearchReports
The short-lived positron-emitting isotopes used in PET imaging are generally produced in a cyclotron and then synthesised on-site before patient administration. Although not requiring the use of a nuclear reactor, this limits the use of PET imaging to centres with access to a cyclotron and synthesis equipment. Therefore, a major development is the recent availability of smaller and cheaper cyclotrons which are designed to produce C-11 and F-18 isotopes economically and on-demand, without the need for radiochemistry or PET accelerator expertise.
The document discusses four key concepts for medical device executives to understand in order to succeed in China's rapidly growing medical devices market. First, executives must seize China's market opportunities as the market is expected to reach $50 billion by 2017. Second, they must understand the Chinese government's important role in regulating the industry and procurement processes. Third, executives should monitor healthcare reforms that could impact market access. Fourth, local competition is growing, so companies must balance global and local strategies to stay competitive. The medical devices market in China offers great potential for growth but also complexity that executives must navigate carefully.
Health insurance exchanges critical success factors for payersApoorv S
The document discusses the key success factors for payers to succeed in health insurance exchanges established under the Affordable Care Act. It states that payers will need to shift from a B2B model to a B2C model focused on individual consumers. Specifically, payers will need to 1) offer a wide range of cost-effective products tailored for individuals and small groups, 2) have a strong presence in the Medicaid market, 3) invest in care management and wellness programs for the uninsured population, and 4) ensure their technology and operations are ready to support exchanges and new members. The exchanges will significantly impact payers and those who adapt to the new retail environment effectively may lead the industry.
Similar to Brazillian Market Favours Entry of Foreign Groups (20)
Part I of pharmaphorum’s interview with James Musick. He discussed his role of heading up social media at Genentech, the similarities between software engineering and drug development. James continues his conversation discussing his thoughts on how social media can best be utilized.
Pharmaphorum’s social pharma face series brings you many people at the forefront of innovation in digital pharma and this month’s expert is no exception.
Global product serialization is well underway and many companies are not adequately prepared for it. The significant capital costs and lack of knowledge in successful implementation are keeping them behind.
Consumers love to save money and companies love to make it. So why do all pharmaceutical manufacturers not supply generics to the animal health industry?
The appeal of potential global consumers for any multinational corporation can be tempting, but with varying regulations on business practices, one needs to exercise caution.
The turmoil engulfing the global economy has forced many industries into reinvention in hope of discovering new growth. Every company faces the daily challenge of business growth; where to find it and how to generate profits from it. Every business leaders’ primary task should be aligning internal resources to capitalise on new growth opportunities quicker and better than competitors.
India is no newcomer to patent protection. The discussion on having a law to protect inventions goes back as far as 1832. After a number of failed attempts, the first Patents Act of India, essentially a copy of British patent law, was finally enacted in 1856. A series of adaptations followed, again modeled on changes in British law.
This document discusses using visual tools to enhance meetings and communication. Visual tools like sticky notes, large paper, and graphic facilitators can help participants process information faster than just verbal or textual information alone. Visual tools provide a permanent record of discussions and help ensure everyone is on the same page by allowing participants to physically organize, discuss, and vote on ideas. Hiring a graphic recorder can cement discussions by capturing them in a blend of words and images. When visual techniques are used in meetings, participation and engagement increases.
Faisal Ahmed is interviewed about his background in digital marketing and views on social media and its use in pharma. He has over 14 years experience in digital, including roles at Amazon and launching multimedia games websites. For the past 3 years, he has worked in healthcare. He defines social media as having evolved into social amplifiers like Facebook and content sites like Tumblr. In pharma, social media is mainly used for PR with a push message rather than interaction. The biggest mistake companies make is not considering the end user perspective. The future of digital marketing will be driven by increasing smartphone usage and 4G enabling more powerful applications.
The Food and Drug Administration Safety and Innovation Act (FDASIA) was recently signed into law by President Obama. The act has been in the works since 2004. It is seen as a strategy to level the playing field by applying a different lower-fee structure to domestic manufacturers and enforcing the same FDA inspection schedule for international facilities.
Generic Pharma 2.0: 10 Potential Industry Game ChangersAmanda Boddington
The generic pharmaceutical industry will look very different in 10 years due to various potential game changers. Companies will need to consider changes to their growth strategies, product selections, and business models. Ten game changers are identified that could disrupt the industry, including increased interest from big pharmaceutical companies in generics, biologic drug patent expirations, new competitors from emerging markets, and increased government protectionism favoring local drug manufacturing. To gain a competitive advantage, companies need to envision how the industry may change and develop strategies to overcome future challenges. Experts can help companies navigate this changing landscape and plot a successful path forward.
Generic Pharma 2.0: 10 Potential Industry Game Changers
Brazillian Market Favours Entry of Foreign Groups
1. NPT | The Community of Big Thinkers
BRAZILIAN MARKET FAVOURS ENTRY OF FOREIGN GROUPS - MULTI-INDUSTRYMULTI-INDUSTRY
Brazilian Market Favours
Entry of Foreign Groups
In order to be successful, it is imperative to know the
singularities of the market
M
uch has been said about the Brazilian market
and the significant conquests its health sector
has recently made compared with past decades.
As the seventh largest in the world, it is a
promising and consolidated market, and one that is very
competitive. The improvement of the population’s acquisitive
power, the growth of formal employment, the aging of the
population, and the introduction of generics more than a
decade ago, have allowed increased access to healthcare services
and have contributed to a higher per-capita consumption of
medication and health services by the population. This growth
is reflected in high occupation rates in hospitals, specifically
privately-owned facilities.
According to IMS Health data, the accumulated growth in the
last five years of the prescription and purchase of medication is
approximately 16% in Brazil. This rate is 2 or 3 times higher
than the global average.The estimated world sales accumulated
growth projection for 2015 is 5% in the most developed
countries, making it 12.6% for Brazil.
The State’s role
Even with Brazil’s already significant victories, there is a lot to
be done.There is still limited access to healthcare by Brazilians,
with approximately 60 million people on private medical plans
or insurances, and the rest, about 130 million, using the public
system. The public healthcare system is efficient in some
aspects, but has some considerable flaws. The early detection
of diseases in the population is still lacking, as well as structural
matters relating to poor allocation of public budgets, and frauds
in public bids - all of which jeopardize the population’s care.
The Farmácia Popular do Brasil Program (Brazilian Popular
Pharmacy Program), which has already accumulated 5 million
registered users, is a clear example of how the government
is acting to solve these problems. Through this program,
the government makes low-cost drugs available for some
therapeutic classes. It acts as a distribution regulator, acquiring
medication for public pharmacies for up to 90% less than
those provided by non-registered pharmacies. This program
attends to the population that suffers from diseases such as
hypertension, diabetes and Parkinson’s disease, among others.
It is a praiseworthy government operation to increase the
population’s access.
Although there is still the need for free competition in the
healthcare services area, there are some sectors in which the
government does need to have a stronger presence. For certain
industries, such as the pharmaceutical industry, state-run
regulation can be beneficial to ensure safety and accountability.
Brazilian challenges and particularities
The Brazilian health market and its high added-value sectors
strongly depend on imports, while research still depends on
external investments. It is a segment in which the commercial
balance is unfavorable. The segment with the most growth -
generics - depends on the expiration of patents on medications.
Biotechnology products represent a vacant opportunity
for Brazil. Of the few initiatives that have involved high-
technology transference, none of them offered a real
transference of technology, nor induced significant innovation
in the country.
Recently, two large private companies have formed a
group, with the government’s support, in order to become
a biogenerics conglomerate. Brazil is just starting in this
market, but regulatory movements in this arena have already
been implemented in the United States and Europe. This is
an exciting opportunity for Brazil, but will certainly require
massive investments and a change to its pharmaceutical
market.
Before now, Brazil has not been the producer of active
principles. Ready raw materials were imported, transformed
and then commercialized. Only a select few in the industry
were able to synthesize them and therefore an important
knowledge basis of infrastructure and technology was not
developed. In the biotechnology case, considerable efforts will
be necessary so that it becomes stable in the country and not
abandoned as in past instances, like synthetics.
New law in 2014
The Brazilian market relies heavily on similar or “branded”
generics that are found on drugstore shelves and depend
exclusively on medical prescriptions. These kinds of
singularities are nonexistent in other, more developed,
markets of the world. These products will suffer the
impact of a new law that will be implemented in 2014
which will demand bioequivalence between drugs.
They will most likely be interchangeable in drugstores,
in the same way it is done today between reference
and generics medications. With this, the influence
of the sales counters is maintained, especially the
large groups that are consolidating, thus benefiting
the product segment that is believed to be the most
profitable.
Many opportunities
Studies have shown that generics are the most
profitable products for drugstores going through
consolidation. The industry is being modernized and
now has the expansion capabilities and resources to
make the change.
It is an ideal moment for companies to extend the
benefits of private health plans to larger sectors of the
population, as well as to build hospital beds outside
large population centers that are better able to attend to the
existing demand. There needs to be more access for those
who are not covered by private plans and the availability of
new products, mainly OTC and nutraceutics - segments still
underdeveloped in Brazil.
The Brazilian market at this time favors the entry of foreign
groups who recognize that eventual assets will be directly
related to what they offer, the results they generate, and the
sustainability of their business before the changes take place.
Entering the Brazilian market depends on a thorough
understanding of the industry,including knowledge of Agência
Nacional de Vigilância Sanitária, commercial, accounting,
financial, and juridical practices. It is fundamental to know all
particularities and subtleties of the market you are entering
and to count on executives who “speak the local language”.
Wolney Alonso is partner director at Entregga (www.entregga.com.br), Brazilian Consultancy, Management and Investments Company focused on the
Healthcare sector. Along with a group of experienced executives led by businessman Omilton Visconde Jr., he participated in last decades of two of the most
important asset acquisitions in the Brazilian Healthcare sector (Biosintética and Segmenta). wolney.alonso@entregga.com.br
To enter Brazil, it is
necessary to count on
deep knowledge on
the Brazilian market...
And if the sales’ accumulated growth projection until 2015 is
of 5% in the most developed countries, it is of 12.6% for Brazil,
ratifying the optimism felt in the segment.
by Wolney Alonso
August 2012